A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells (Q46093207)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 January 2009

Language	Label	Description	Also known as
English	A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells	scientific article published on 25 January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

0 references

0 references

author name string

Jing Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

Masato Eto

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

Masahiro Akishita

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

Tetsuro Okabe

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

Yasuyoshi Ouchi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

publication date

25 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

51

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

21-28

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Mammalian MAP kinase signalling cascades

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Ablation of NF-kappaB expression by small interference RNA prevents the dysfunction of human umbilical vein endothelial cells induced by high glucose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Raloxifene slows down the progression of intima-media thickness in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Estrogen decreases TNF-alpha and oxidized LDL induced apoptosis in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Menopause and risk of cardiovascular disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Akt plays a central role in the anti-apoptotic effect of estrogen in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

The inflammatory cytokine response of cholesterol-enriched macrophages is dampened by stimulated pinocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Ligand control of coregulator recruitment to nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

TNF-induced signaling in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Selective estrogen receptor modulators prevent neointima formation after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

The effects of raloxifene and simvastatin on plasma lipids and endothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Mitogen-activated protein kinases in apoptosis regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Comparative analyses of mechanistic differences among antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Raloxifene analogue LY117018 suppresses oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.003

7 January 2021

Identifiers

10.1016/J.VPH.2009.01.003

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19275968

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46093207&oldid=2091588547"